Corvus Pharmaceuticals, Inc.
CRVS
$7.60
-$0.22-2.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.72% | 68.30% | -14.92% | 24.76% | -11.84% |
| Total Receivables | 33.59% | 14.10% | 5.09% | -2.26% | 81.15% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -33.03% | -34.32% | 7.87% | 21.13% | -23.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -12.16% | 43.30% | -68.98% | 165.81% | 71.24% |
| Total Current Assets | -11.66% | 66.58% | -16.39% | 26.76% | -11.06% |
|
|
|||||
| Total Current Assets | -11.66% | 66.58% | -16.39% | 26.76% | -11.06% |
| Net Property, Plant & Equipment | -8.96% | 0.08% | -5.12% | 191.87% | -40.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.10% | -0.48% | -0.47% | 150.79% | 95.35% |
| Total Assets | -10.05% | 50.51% | -13.74% | 17.16% | -8.90% |
|
|
|||||
| Total Accounts Payable | -37.07% | 139.83% | -49.34% | 37.85% | 54.41% |
| Total Accrued Expenses | 10.46% | 30.55% | 4.05% | -9.89% | -6.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.76% | 11.29% | 72.43% | -47.74% | -49.43% |
| Total Finance Division Other Current Liabilities | 63.58% | -91.51% | -86.04% | -27.66% | 449.35% |
| Total Other Current Liabilities | 63.58% | -91.51% | -86.04% | -27.66% | 449.35% |
| Total Current Liabilities | -5.07% | -8.34% | -73.79% | -23.71% | 248.00% |
|
|
|||||
| Total Current Liabilities | -5.07% | -8.34% | -73.79% | -23.71% | 248.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.19% | -12.71% | -10.99% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -5.71% | -8.70% | -72.17% | -21.69% | 248.00% |
|
|
|||||
| Common Stock & APIC | 0.34% | 8.97% | 0.36% | 8.25% | 0.20% |
| Retained Earnings | -2.61% | -2.09% | 3.83% | -3.15% | -11.67% |
| Treasury Stock & Other | 7.67% | 8.45% | 2.64% | -74.53% | 45.54% |
| Total Common Equity | -10.54% | 62.65% | 51.45% | 162.45% | -75.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.54% | 62.65% | 51.45% | 162.45% | -75.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.54% | 62.65% | 51.45% | 162.45% | -75.78% |
|
|
|||||